<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>BioMedGPT-Mol: Multi-task Learning for Molecular Understanding and Generation - Health AI Hub</title>
    <meta name="description" content="BioMedGPT-Mol is a novel molecular language model, adapted from general-purpose reasoning models via multi-task learning, designed to enhance molecular understa">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>BioMedGPT-Mol: Multi-task Learning for Molecular Understanding and Generation</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.04629v1" target="_blank">2512.04629v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-04
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Chenyang Zuo, Siqi Fan, Zaiqing Nie
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.AI
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.04629v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.04629v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">BioMedGPT-Mol is a novel molecular language model, adapted from general-purpose reasoning models via multi-task learning, designed to enhance molecular understanding and generation. Leveraging a comprehensive dataset and structured training, it achieves remarkable performance across various molecular benchmarks and demonstrates competitive capability in retrosynthetic planning.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This work directly impacts biomedical research by providing advanced AI tools for small molecule drug discovery and development. By improving molecular understanding, generation, and synthesis planning, it can significantly accelerate the identification and optimization of new therapeutic candidates.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>BioMedGPT-Mol is an AI application designed to accelerate and optimize the early stages of drug discovery. It functions as a molecular language model for understanding and generating new small molecules, and as an end-to-end retrosynthetic planner, which is critical for designing the synthesis pathways for potential drug candidates. This directly supports the development of new medicines and therapeutic agents.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Introduces BioMedGPT-Mol, a molecular language model efficiently adapted from general-purpose reasoning models.</li>
                    
                    <li>Designed to support multi-task learning for molecular understanding and generation, crucial for small molecule drug development.</li>
                    
                    <li>Utilizes a large-scale, comprehensive, and high-quality training dataset curated by unifying existing public instruction datasets.</li>
                    
                    <li>Trained through a meticulously designed multi-task learning framework, enabling specialized molecular capabilities.</li>
                    
                    <li>Achieves remarkable performance on consolidated benchmarks including LlaSMol, TOMG-Bench, and MuMOInstruct.</li>
                    
                    <li>Demonstrates competitive capability as an end-to-end retrosynthetic planner, as evaluated on RetroBench.</li>
                    
                    <li>Highlights the efficacy of post-training general-purpose reasoning models into professional molecular LMs through a well-structured multi-task curriculum, with potential for extension to other biomedical domains.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The methodology involves adapting general-purpose reasoning large language models (LLMs) for molecular science. A large-scale, comprehensive training dataset was assembled by curating and unifying existing public instruction datasets. The model was then fine-tuned using a meticulously designed multi-task learning framework. Performance was evaluated on a consolidated benchmark derived from LlaSMol, TOMG-Bench, and MuMOInstruct, and specifically for retrosynthetic planning on RetroBench.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>['BioMedGPT-Mol exhibits remarkable performance on a range of molecular understanding and generation tasks.', 'General-purpose reasoning models can be effectively and efficiently post-trained into specialized professional molecular language models through a structured multi-task curriculum.', 'The model demonstrates competitive capability as an end-to-end retrosynthetic planner, a critical component of chemical synthesis in drug development.']</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This technology has the potential to significantly streamline and accelerate the preclinical stages of small molecule drug development. By facilitating more efficient and accurate design, optimization, and synthesis planning of drug candidates, it could reduce the time and cost associated with bringing new therapies to patients, ultimately accelerating access to novel treatments.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state specific limitations of the BioMedGPT-Mol model or the experimental setup. It primarily focuses on the achieved performance and potential.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The authors anticipate that their multi-task learning approach for specialized AI can be extended to other biomedical scientific domains, suggesting broader applicability beyond molecular science.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Drug discovery</span>
                    
                    <span class="tag">Pharmaceutical research</span>
                    
                    <span class="tag">Chemical synthesis</span>
                    
                    <span class="tag">Medicinal chemistry</span>
                    
                    <span class="tag">Computational drug design</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">BioMedGPT-Mol</span>
                    
                    <span class="tag tag-keyword">molecular language model</span>
                    
                    <span class="tag tag-keyword">multi-task learning</span>
                    
                    <span class="tag tag-keyword">drug discovery</span>
                    
                    <span class="tag tag-keyword">retrosynthetic planning</span>
                    
                    <span class="tag tag-keyword">small molecules</span>
                    
                    <span class="tag tag-keyword">AI in medicine</span>
                    
                    <span class="tag tag-keyword">generative AI</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Molecules play a crucial role in biomedical research and discovery, particularly in the field of small molecule drug development. Given the rapid advancements in large language models, especially the recent emergence of reasoning models, it is natural to explore how a general-purpose language model can be efficiently adapted for molecular science applications. In this work, we introduce BioMedGPT-Mol, a molecular language model designed to support molecular understanding and generation tasks. By curating and unifying existing public instruction datasets, we have assembled a large-scale, comprehensive, and high-quality training dataset. The model is then fine-tuned through a meticulously designed multi-task learning framework. On a consolidated benchmark derived from LlaSMol, TOMG-Bench, and MuMOInstruct, BioMedGPT-Mol achieves remarkable performance. Our experimental results demonstrate that a general-purpose reasoning model can be effectively and efficiently post-trained into a professional molecular language model through a well-structured multi-task curriculum. Leveraging the power of it, we further explore retrosynthetic planning task, and the performance on RetroBench demonstrates its competitive capability of acting as an end-to-end retrosynthetic planner. We anticipate that our approach can be extended to other biomedical scientific domains.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>